RENACIDIN Drug Patent Profile
✉ Email this page to a colleague
When do Renacidin patents expire, and what generic alternatives are available?
Renacidin is a drug marketed by United Guardian and is included in one NDA.
The generic ingredient in RENACIDIN is citric acid; gluconolactone; magnesium carbonate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the citric acid; gluconolactone; magnesium carbonate profile page.
Summary for RENACIDIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for RENACIDIN |
What excipients (inactive ingredients) are in RENACIDIN? | RENACIDIN excipients list |
DailyMed Link: | RENACIDIN at DailyMed |
Pharmacology for RENACIDIN
Drug Class | Anti-coagulant Calculi Dissolution Agent |
Mechanism of Action | Acidifying Activity Calcium Chelating Activity Irrigation |
Physiological Effect | Decreased Coagulation Factor Activity |
Anatomical Therapeutic Chemical (ATC) Classes for RENACIDIN
US Patents and Regulatory Information for RENACIDIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United Guardian | RENACIDIN | citric acid; gluconolactone; magnesium carbonate | SOLUTION;IRRIGATION | 019481-001 | Oct 2, 1990 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |